People | July 31, 2025
Bristol Myers Squibb appoints Cristian Massacesi as EVP, Chief Medical Officer, and Head of Development
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This marks the fourth acquisition by Corona Remedies from multinational corporations
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
The company’s largest center for medical device applications, serving the entire Asian market
To streamline complex medical writing workflows with GenAI
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Subscribe To Our Newsletter & Stay Updated
